Compound library design for target families
- PMID: 19727610
- DOI: 10.1007/978-1-60761-274-2_2
Compound library design for target families
Abstract
Chemogenomics is a modern approach to analysis of the biological effect of a wide array of small molecule compounds on a large set of homologous receptors or other macromolecular drug targets. However, the relative productivity of the method and the extremely high-cost procedure jointly force the scientist to use additional computational tools for rational compound library design and selection. The present chapter will focus specifically on application of a predictive mapping computational technology in the context of the fundamental principles of chemogenomic approach to foster rational drug design and derive information from the simultaneous biological evaluation of multiple compounds on a set of coherent biological targets.
Similar articles
-
Organizing bioactive compound discovery in target families.Methods Mol Biol. 2009;575:1-19. doi: 10.1007/978-1-60761-274-2_1. Methods Mol Biol. 2009. PMID: 19727609 Review.
-
Chemogenomics: structuring the drug discovery process to gene families.Drug Discov Today. 2006 Oct;11(19-20):880-8. doi: 10.1016/j.drudis.2006.08.013. Epub 2006 Sep 7. Drug Discov Today. 2006. PMID: 16997137 Review.
-
A chemogenomic approach to drug discovery: focus on cardiovascular diseases.Drug Discov Today. 2009 May;14(9-10):479-85. doi: 10.1016/j.drudis.2009.02.010. Epub 2009 Mar 5. Drug Discov Today. 2009. PMID: 19429507 Review.
-
Dimerization of chemokine receptors in living cells: key to receptor function and novel targets for therapy.Drug Discov Today. 2008 Jul;13(13-14):625-32. doi: 10.1016/j.drudis.2008.04.004. Epub 2008 Jun 3. Drug Discov Today. 2008. PMID: 18598920 Review.
-
G-protein-coupled receptor-focused drug discovery using a target class platform approach.Drug Discov Today. 2009 Mar;14(5-6):231-40. doi: 10.1016/j.drudis.2008.11.011. Epub 2009 Jan 22. Drug Discov Today. 2009. PMID: 19121411 Review.
Cited by
-
Generative network complex (GNC) for drug discovery.Commun Inf Syst. 2019;19(3):241-277. doi: 10.4310/cis.2019.v19.n3.a2. Commun Inf Syst. 2019. PMID: 34257523 Free PMC article.
-
Motif mediated protein-protein interactions as drug targets.Cell Commun Signal. 2016 Mar 2;14:8. doi: 10.1186/s12964-016-0131-4. Cell Commun Signal. 2016. PMID: 26936767 Free PMC article. Review.
-
Deep learning-guided structural analysis of a novel bacteriophage KPP105 against multidrug-resistant Klebsiella pneumoniae.Comput Struct Biotechnol J. 2025 May 1;27:1827-1837. doi: 10.1016/j.csbj.2025.04.032. eCollection 2025. Comput Struct Biotechnol J. 2025. PMID: 40470315 Free PMC article.
-
Non-dopamine receptor ligands for the treatment of Parkinson's disease. Insight into the related chemical/property space.Mol Divers. 2016 Feb;20(1):345-65. doi: 10.1007/s11030-015-9598-y. Epub 2015 May 9. Mol Divers. 2016. PMID: 25956815 Review.
-
Designing antimicrobial peptides: form follows function.Nat Rev Drug Discov. 2011 Dec 16;11(1):37-51. doi: 10.1038/nrd3591. Nat Rev Drug Discov. 2011. PMID: 22173434 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources